Home

Kleid Stereo Pflege met tumor Egal ob Bank Zwilling

Has PD-1 MET Its Match in Hepatocellular Carcinoma? - Gastroenterology
Has PD-1 MET Its Match in Hepatocellular Carcinoma? - Gastroenterology

Roles of the HGF/Met signaling in head and neck squamous cell carcinoma:  Focus on tumor immunity (Review)
Roles of the HGF/Met signaling in head and neck squamous cell carcinoma: Focus on tumor immunity (Review)

Immunological regulation of resistance to MET-targeted therapy. MET... |  Download Scientific Diagram
Immunological regulation of resistance to MET-targeted therapy. MET... | Download Scientific Diagram

JCI - Linking MLL and the HGF-MET signaling pathway in liver cancer
JCI - Linking MLL and the HGF-MET signaling pathway in liver cancer

Cross-activating c-Met/β1 integrin complex drives metastasis and invasive  resistance in cancer | PNAS
Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer | PNAS

Suppression of hepatic tumor growth and metastasis by metronomic therapy in  a rat model of hepatocellular carcinoma | Experimental & Molecular Medicine
Suppression of hepatic tumor growth and metastasis by metronomic therapy in a rat model of hepatocellular carcinoma | Experimental & Molecular Medicine

EMT, MET, Plasticity, and Tumor Metastasis: Trends in Cell Biology
EMT, MET, Plasticity, and Tumor Metastasis: Trends in Cell Biology

Cancers | Free Full-Text | Tyrosine Kinase c-MET as Therapeutic Target for  Radiosensitization of Head and Neck Squamous Cell Carcinomas
Cancers | Free Full-Text | Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas

Knockdown of RON receptor kinase delays but does not prevent tumor  progression while enhancing HGF/MET signaling in pancreatic cancer cell  lines | Oncogenesis
Knockdown of RON receptor kinase delays but does not prevent tumor progression while enhancing HGF/MET signaling in pancreatic cancer cell lines | Oncogenesis

Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in  Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling - ScienceDirect
Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling - ScienceDirect

Overexpression of MACC1 and the association with hepatocyte growth factor/c- Met in epithelial ovarian cancer
Overexpression of MACC1 and the association with hepatocyte growth factor/c- Met in epithelial ovarian cancer

Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable  Mediator of Antiangiogenic Therapy Resistance | Clinical Cancer Research
Gene Expression Profile Identifies Tyrosine Kinase c-Met as a Targetable Mediator of Antiangiogenic Therapy Resistance | Clinical Cancer Research

Targeting MET in Cancer: Obstacles and Potentials | Insight Medical  Publishing
Targeting MET in Cancer: Obstacles and Potentials | Insight Medical Publishing

When cancer “met” its match: New study shows | EurekAlert!
When cancer “met” its match: New study shows | EurekAlert!

c-Met Proto-oncogene | Targeting Overexpression
c-Met Proto-oncogene | Targeting Overexpression

Frontiers | Targeting the HGF/MET Axis in Cancer Therapy: Challenges in  Resistance and Opportunities for Improvement | Cell and Developmental  Biology
Frontiers | Targeting the HGF/MET Axis in Cancer Therapy: Challenges in Resistance and Opportunities for Improvement | Cell and Developmental Biology

Targeting c-MET by Tivantinib through synergistic activation of JNK/c-jun  pathway in cholangiocarcinoma | Cell Death & Disease
Targeting c-MET by Tivantinib through synergistic activation of JNK/c-jun pathway in cholangiocarcinoma | Cell Death & Disease

MET inhibitors significantly inhibit tumor progression of SBC-5... |  Download Scientific Diagram
MET inhibitors significantly inhibit tumor progression of SBC-5... | Download Scientific Diagram

EMT, MET, Plasticity, and Tumor Metastasis: Trends in Cell Biology
EMT, MET, Plasticity, and Tumor Metastasis: Trends in Cell Biology

Cross-activating c-Met/β1 integrin complex drives metastasis and invasive  resistance in cancer | PNAS
Cross-activating c-Met/β1 integrin complex drives metastasis and invasive resistance in cancer | PNAS

MET Signaling: Novel Targeted Inhibition and Its Clinical Development in  Lung Cancer - Journal of Thoracic Oncology
MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer - Journal of Thoracic Oncology

IJMS | Free Full-Text | MET/HGF Co-Targeting in Pancreatic Cancer: A Tool  to Provide Insight into the Tumor/Stroma Crosstalk
IJMS | Free Full-Text | MET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma Crosstalk

Targeting c-Met to Improve Immune Checkpoint Inhibition in Metastatic Renal  Cell Carcinoma - European Urology
Targeting c-Met to Improve Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma - European Urology

MET-dependent solid tumours — molecular diagnosis and targeted therapy |  Nature Reviews Clinical Oncology
MET-dependent solid tumours — molecular diagnosis and targeted therapy | Nature Reviews Clinical Oncology

Targeting the HGF/Met signalling pathway in cancer - European Journal of  Cancer
Targeting the HGF/Met signalling pathway in cancer - European Journal of Cancer

IJMS | Free Full-Text | Tumor Inhibitory Effect of IRCR201, a Novel  Cross-Reactive c-Met Antibody Targeting the PSI Domain
IJMS | Free Full-Text | Tumor Inhibitory Effect of IRCR201, a Novel Cross-Reactive c-Met Antibody Targeting the PSI Domain